BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37340919)

  • 1. [Identification of immune-related prognostic signature for colon adenocarcinoma based on weighted gene co-expression network analysis].
    He X; Wan S; He Q; Hou J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):509-515. PubMed ID: 37340919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
    Jiang C; Liu Y; Wen S; Xu C; Gu L
    Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
    Cheng X; Wei Y; Fu Y; Li J; Han L
    Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
    Ren Y; He S; Feng S; Yang W
    Front Public Health; 2022; 10():916364. PubMed ID: 35712285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.
    Wang Y; Huang X; Chen S; Jiang H; Rao H; Lu L; Wen F; Pei J
    Curr Oncol; 2022 Sep; 29(9):6573-6593. PubMed ID: 36135086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
    Gao H; Xing F
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
    Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
    PeerJ; 2023; 11():e16477. PubMed ID: 38025763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma.
    Jiang Z; Xu J; Zhang S; Lan H; Bao Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10813-10829. PubMed ID: 37316691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
    Zhang C; Zhao Z; Liu H; Yao S; Zhao D
    Front Genet; 2021; 12():657658. PubMed ID: 34322151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
    Sun Z; Li G; Shang D; Zhang J; Ai L; Liu M
    Front Immunol; 2022; 13():988303. PubMed ID: 36275690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven bacterial response-related genes are biomarkers for colon cancer.
    Xiong Z; Li W; Luo X; Lin Y; Huang W; Zhang S
    BMC Bioinformatics; 2023 Mar; 24(1):103. PubMed ID: 36941538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
    Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
    J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
    Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
    Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.